Omnicell Inc (NASDAQ:OMCL) — Market Cap & Net Worth
Market Cap & Net Worth: Omnicell Inc (OMCL)
Omnicell Inc (NASDAQ:OMCL) has a market capitalization of $1.81 Billion ($1.81 Billion) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6647 globally and #2012 in its home market, demonstrating a -4.89% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Omnicell Inc's stock price $39.90 by its total outstanding shares 45435918 (45.44 Million). Review Omnicell Inc total liabilities to assess the company's total debt and financial obligations.
Omnicell Inc Market Cap History: 2015 to 2026
Omnicell Inc's market capitalization history from 2015 to 2026. Data shows growth from $1.41 Billion to $1.81 Billion (2.44% CAGR).
Index Memberships
Omnicell Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.07% | #168 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #716 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.65 Trillion | 0.13% | #341 of 602 |
Weight: Omnicell Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Omnicell Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Omnicell Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.74x
Omnicell Inc's market cap is 1.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1003.04x
Omnicell Inc's market cap is 1003.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.54 Billion | $692.62 Million | $603.00K | 2.22x | 2554.36x |
| 2017 | $2.20 Billion | $716.16 Million | $20.61 Million | 3.08x | 106.95x |
| 2018 | $2.78 Billion | $787.31 Million | $37.73 Million | 3.53x | 73.75x |
| 2019 | $3.71 Billion | $897.03 Million | $61.34 Million | 4.14x | 60.53x |
| 2020 | $5.45 Billion | $892.21 Million | $32.19 Million | 6.11x | 169.39x |
| 2021 | $8.20 Billion | $1.13 Billion | $77.85 Million | 7.24x | 105.31x |
| 2022 | $2.29 Billion | $1.30 Billion | $5.65 Million | 1.77x | 405.61x |
| 2023 | $1.71 Billion | $1.15 Billion | -$20.37 Million | 1.49x | N/A |
| 2024 | $2.02 Billion | $1.11 Billion | $12.53 Million | 1.82x | 161.42x |
| 2025 | $2.06 Billion | $1.18 Billion | $2.05 Million | 1.74x | 1003.04x |
Competitor Companies of OMCL by Market Capitalization
Companies near Omnicell Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Omnicell Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #1017 globally with a market cap of $26.54 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1955 globally with a market cap of $12.13 Billion USD ( AU$17.14 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2173 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2489 globally with a market cap of $8.78 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1017 | Veeva Systems Inc Class A | NYSE:VEEV | $26.54 Billion | $163.38 |
| #1955 | Pro Medicus Ltd | AU:PME | $12.13 Billion | AU$164.11 |
| #2173 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $64.14 |
| #2489 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.78 Billion | $50.56 |
Omnicell Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Omnicell Inc's market cap moved from $1.41 Billion to $ 1.81 Billion, with a yearly change of 2.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.81 Billion | -11.92% |
| 2025 | $2.06 Billion | +1.75% |
| 2024 | $2.02 Billion | +18.31% |
| 2023 | $1.71 Billion | -25.37% |
| 2022 | $2.29 Billion | -72.06% |
| 2021 | $8.20 Billion | +50.34% |
| 2020 | $5.45 Billion | +46.87% |
| 2019 | $3.71 Billion | +33.44% |
| 2018 | $2.78 Billion | +26.27% |
| 2017 | $2.20 Billion | +43.07% |
| 2016 | $1.54 Billion | +9.07% |
| 2015 | $1.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Omnicell Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.81 Billion USD |
| MoneyControl | $1.81 Billion USD |
| MarketWatch | $1.81 Billion USD |
| marketcap.company | $1.81 Billion USD |
| Reuters | $1.81 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Omnicell Inc
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for th… Read more